Author:
Xiao Yang,Leach John,Wang Jun,Martin James F.
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Reference42 articles.
1. Edgar BA. From cell structure to transcription: Hippo forges a new path. Cell. 2006;124(2):267–73.
2. Heallen T, Zhang M, Wang J, Bonilla-Claudio M, Klysik E, Johnson RL, et al. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science. 2011;332(6028):458–61. Pioneer work demonstrated Hippo signaling interacting with Wnt signaling suppresses cardiomyocyte proliferation.
3. von Gise A, Lin Z, Schlegelmilch K, Honor LB, Pan GM, Buck JN, et al. YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy. Proc Natl Acad Sci U S A. 2012;109(7):2394–9. Follow-up study of Heallen et al Science 2011 demonstrated Hippo signaling effect Yap acting through TEAD is sufficient to stimulate neonatal cardiomyocyte proliferation.
4. Xin M, Kim Y, Sutherland LB, Qi X, McAnally J, Schwartz RJ, et al. Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size. Sci Signal. 2011;4(196):ra70. Follow-up study of Heallen et al Science 2011, showed Yap connects to β-catenin through activating IGF signaling in cardiac growth regulation.
5. Zhou D, Conrad C, Xia F, Park JS, Payer B, Yin Y, et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell. 2009;16(5):425–38.
Cited by
51 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献